Cardiovascular disease is the major cause of death in women in developed countries. Dyslipidemia is highly prevalent in women, particularly after the menopause. Elevated low-density lipoprotein cholesterol (LDL-C) has been identified as the key lipid parameter in both genders whereas HDL-cholesterol and triglycerides have been more closely associated, in some studies, with cardiovascular risk in women. Menopause has been shown to be associated with an increase in total and LDL-cholesterol and a decrease in HDL-cholesterol (predominantly in the HDL2 subfraction). Despite its beneficial effects on the lipid profile, hormone replacement therapy is not recommended for primary or secondary prevention of cardiovascular disease in women. The latest meta-analysis of statin trials with gender-specific outcomes showed a similar benefit in women and men. The addition of ezetimibe to simvastatin in patients with acute coronary syndromes showed a further reduction of the primary endpoint in both genders. While there are no gender-related differences in drug treatment of dyslipidemia, current guidelines, to avoid overtreatment, strongly suggest risk estimation before initiating lipid-lowering treatment in women without manifest cardiovascular disease.

Center for Cardiovascular Prevention Charles University Prague 1st Faculty of Medicine and Thomayer Hospital Videnska 800 140 59 Prague 4 Czech Republic

Zobrazit více v PubMed

Clin Pharmacol Ther. 2006 May;79(5):480-8 PubMed

Obstet Gynecol. 2006 Jun;107(6):1453-72 PubMed

JAMA. 1987 Apr 24;257(16):2176-80 PubMed

Atherosclerosis. 2000 Oct;152(2):441-9 PubMed

Am J Epidemiol. 1996 Aug 1;144(3):247-54 PubMed

Ann Intern Med. 1979 Jan;90(1):85-91 PubMed

Arch Intern Med. 1993 Oct 11;153(19):2209-16 PubMed

Am J Med Sci. 2006 Jan;331(1):10-6 PubMed

BMJ. 2012 May 10;344:e2990 PubMed

N Engl J Med. 2011 Dec 15;365(24):2255-67 PubMed

J Am Coll Cardiol. 2006 May 2;47(9):1741-53 PubMed

J Cardiovasc Risk. 1996 Apr;3(2):213-9 PubMed

J Lipid Res. 1994 May;35(5):779-92 PubMed

N Engl J Med. 2013 Apr 4;368(14):1279-90 PubMed

N Engl J Med. 2001 Dec 20;345(25):1787-93 PubMed

Fertil Steril. 2001 May;75(5):898-915 PubMed

J Hum Hypertens. 2005 Jun;19(6):451-5 PubMed

Circulation. 2001 Sep 4;104(10):1108-13 PubMed

Physiol Res. 2000;49(2):233-9 PubMed

J Womens Health (Larchmt). 2004 Dec;13(10):1119-26 PubMed

Eur Heart J. 2011 Jul;32(14):1769-818 PubMed

Eur Heart J. 2013 Oct;34(39):3035-87 PubMed

Circulation. 1993 Apr;87(4):1135-41 PubMed

J Clin Endocrinol Metab. 1982 Jun;54(6):1113-7 PubMed

J Am Coll Cardiol. 2009 Jan 20;53(3):221-31 PubMed

Int J Epidemiol. 1990 Mar;19(1):42-8 PubMed

Circulation. 2007 Mar 20;115(11):1481-501 PubMed

Eur Heart J. 2014 Nov 7;35(42):2950-9 PubMed

BMJ. 1994 Feb 5;308(6925):367-72 PubMed

J Am Coll Cardiol. 2001 Feb;37(2):425-30 PubMed

Stroke. 2004 Dec;35(12):2902-9 PubMed

Am J Cardiol. 2015 Jan 1;115(1):21-6 PubMed

Gynecol Endocrinol. 1997 Aug;11(4):281-8 PubMed

Lancet. 2010 Nov 13;376(9753):1670-81 PubMed

Am Heart J. 2014 Aug;168(2):205-12.e1 PubMed

Prev Med. 1984 Mar;13(2):141-54 PubMed

Lancet. 2007 Dec 1;370(9602):1829-39 PubMed

JAMA. 2006 Feb 8;295(6):655-66 PubMed

Circulation. 2014 Jan 21;129(3):e28-e292 PubMed

Arch Intern Med. 2004 Apr 12;164(7):741-7 PubMed

Arch Intern Med. 1994 Oct 24;154(20):2349-55 PubMed

Circulation. 2007 Jan 30;115(4):450-8 PubMed

N Engl J Med. 1998 Nov 5;339(19):1349-57 PubMed

Am J Cardiol. 2000 Aug 1;86(3):299-304 PubMed

Circulation. 2011 Mar 22;123(11):1243-62 PubMed

Am J Cardiol. 1987 Jun 1;59(15):1271-6 PubMed

BMJ. 1998 Apr 4;316(7137):1043-7 PubMed

Expert Rev Cardiovasc Ther. 2012 Mar;10(3):363-78 PubMed

Mayo Clin Proc. 1998 Aug;73(8):735-8 PubMed

Clin Chem Lab Med. 2007;45(9):1190-8 PubMed

N Engl J Med. 2010 Apr 29;362(17):1563-74 PubMed

Am J Epidemiol. 1987 Nov;126(5):922-8 PubMed

Lancet. 2008 Jan 12;371(9607):117-25 PubMed

J Clin Endocrinol Metab. 2011 Apr;96(4):1169-74 PubMed

Fertil Steril. 2007 Aug;88(2):310-6 PubMed

J Clin Endocrinol Metab. 1988 Jul;67(1):30-5 PubMed

Circulation. 1989 Jan;79(1):8-15 PubMed

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):304-14 PubMed

Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45 PubMed

N Engl J Med. 1988 Nov 17;319(20):1313-7 PubMed

Eur Heart J. 2012 Jul;33(13):1635-701 PubMed

Am J Epidemiol. 2001 May 15;153(10):939-45 PubMed

Am Heart J. 1987 Dec;114(6):1467-503 PubMed

J Clin Endocrinol Metab. 2005 Jul;90(7):3863-70 PubMed

JAMA. 1995 Jan 18;273(3):199-208 PubMed

Eur Heart J. 2014 Apr;35(15):960-8 PubMed

N Engl J Med. 1999 Jul 22;341(4):217-25 PubMed

BMJ. 2009 Jun 30;338:b2376 PubMed

J Am Coll Cardiol. 2015 Jan 6;65(1):43-51 PubMed

Ther Adv Drug Saf. 2014 Oct;5(5):201-13 PubMed

Am J Cardiol. 2010 May 1;105(9):1289-96 PubMed

JAMA. 2000 Jul 5;284(1):72-8 PubMed

JAMA. 2007 Jul 18;298(3):309-16 PubMed

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2742-8 PubMed

JAMA. 2001 Mar 28;285(12):1585-91 PubMed

Lancet. 2004 Sep 11-17;364(9438):937-52 PubMed

Int J Cardiol. 2010 Jan 7;138(1):25-31 PubMed

Circulation. 1994 Oct;90(4):1688-95 PubMed

J Hypertens. 2010 Nov;28(11):2196-203 PubMed

J Am Coll Cardiol. 2012 Feb 7;59(6):572-82 PubMed

Stroke. 2006 Feb;37(2):345-50 PubMed

Maturitas. 2001 May 30;38(3):297-304 PubMed

N Engl J Med. 1987 Nov 12;317(20):1237-45 PubMed

Am J Epidemiol. 1993 Feb 15;137(4):383-92 PubMed

Educ Health (Abingdon). 2003 Jul;16(2):230 PubMed

BMJ. 1999 Jun 12;318(7198):1579-83 PubMed

JAMA. 1984 Jan 20;251(3):351-64 PubMed

Lancet. 2005 Oct 8;366(9493):1267-78 PubMed

Gend Med. 2006 Dec;3(4):279-91 PubMed

JAMA. 1998 Dec 16;280(23):2001-7 PubMed

Thyroid. 2002 Apr;12(4):287-93 PubMed

Circulation. 1996 Jul 1;94(1):61-6 PubMed

Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2448-55 PubMed

Metabolism. 2001 Mar;50(3):370-6 PubMed

Lancet. 2005 Nov 26;366(9500):1849-61 PubMed